Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | ODM-208 |
| Trade Name | |
| Synonyms | ODM208|ODM 208|MK-5684|MK5684|MK 5684|Opevesostat |
| Drug Descriptions |
ODM-208 is a selective inhibitor of CYP11A1, which potentially inhibits steroid biosynthesis and tumor growth (PMID: 36129801). |
| DrugClasses | |
| CAS Registry Number | 2231294-96-3 |
| NCIT ID | C156744 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Cabazitaxel + ODM-208 | Cabazitaxel ODM-208 | 0 | 1 |
| Dexamethasone + Fludrocortisone + ODM-208 | Dexamethasone Fludrocortisone ODM-208 | 0 | 3 |
| Docetaxel + ODM-208 | Docetaxel ODM-208 | 0 | 1 |
| Ifinatamab deruxtecan + ODM-208 | Ifinatamab deruxtecan ODM-208 | 0 | 1 |
| ODM-208 | ODM-208 | 0 | 2 |
| ODM-208 + Olaparib | ODM-208 Olaparib | 0 | 1 |